ArticleMaterials today. Bio2026

Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio

Yue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.